Home » SANGAMO, PFIZER ENTER COLLABORATION
SANGAMO, PFIZER ENTER COLLABORATION
Biotech company Sangamo BioSciences is collaborating with drugmaker Pfizer to produce enhanced proteins. Financial terms of the agreement were not disclosed. Under the agreement, Pfizer will fund Sangamo's research and the company will supply Pfizer with its proprietary zinc finger DNA binding protein, or ZFP, to assess for pharmaceutical production.
Forbes (http://www.forbes.com/work/feeds/ap/2005/01/05/ap1739915.html)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
23May
-
30May
-
13Jun
-
20Jun
-
21Oct